Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities

Ann Rheum Dis. 2019 Aug;78(8):e76. doi: 10.1136/annrheumdis-2018-213821. Epub 2018 Jun 23.

Authors

Philippe Willems¹, Ellen De Langhe², René Westhovens³, Steven Vanderschueren⁴, Daniel Blockmans⁴, Xavier Bossuyt⁵

Affiliations

¹ Laboratory Medicine, University Hospitals Leuven, Leuven, Flanders, Belgium.
² Rheumatology, University Hospitals Leuven, Leuven, Flanders, Belgium.
³ Rheumatology, University Hospitals Leuven, Leuven, Belgium.
⁴ General internal medicine, University Hospitals Leuven, Leuven, Belgium.
⁵ Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.

PMID: 29936439
DOI: 10.1136/annrheumdis-2018-213821

No abstract available

Keywords: autoantibodies; autoimmune diseases; systemic lupus erythematosus.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antibodies, Antinuclear*
Autoantibodies
Humans
Lupus Erythematosus, Systemic*

Substances

Antibodies, Antinuclear
Autoantibodies